Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24234 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-275 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-065 |
filingDate |
2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2004-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6588d6f52db4e2e17db55d22ffce9615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d1fe3005a627e09a85909f1d95ac7c |
publicationDate |
2004-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6723329-B2 |
titleOfInvention |
Use of parapox B2L protein to modify immune responses to administered antigens |
abstract |
The Parapox B2L virus envelope protein is used as an adjuvant to enhance a subject's response to an administered antigen. Both antibody and cellular immune responses can be modified. B2L protein is particularly useful as an adjuvant for poorly immunogenic tumor vaccines and subunit vaccines, such as those useful for preventing and/or treating flu, tuberculosis, respiratory syncytial virus, anthrax and HIV. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004213807-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102888422-A |
priorityDate |
2001-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |